» Articles » PMID: 22110661

Computational Modeling of Interactions Between Multiple Myeloma and the Bone Microenvironment

Overview
Journal PLoS One
Date 2011 Nov 24
PMID 22110661
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It has been postulated that positive feedback loops in the interactions between MM cells and the bone microenvironment form reinforcing 'vicious cycles', resulting in more bone resorption and MM cell population growth in the bone microenvironment. Despite many identified MM-bone interactions, the combined effect of these interactions and their relative importance are unknown. In this paper, we develop a computational model of MM-bone interactions and clarify whether the intercellular signaling mechanisms implemented in this model appropriately drive MM disease progression. This new computational model is based on the previous bone remodeling model of Pivonka et al., and explicitly considers IL-6 and MM-BMSC (bone marrow stromal cell) adhesion related pathways, leading to formation of two positive feedback cycles in this model. The progression of MM disease is simulated numerically, from normal bone physiology to a well established MM disease state. Our simulations are consistent with known behaviors and data reported for both normal bone physiology and for MM disease. The model results suggest that the two positive feedback cycles identified for this model are sufficient to jointly drive the MM disease progression. Furthermore, quantitative analysis performed on the two positive feedback cycles clarifies the relative importance of the two positive feedback cycles, and identifies the dominant processes that govern the behavior of the two positive feedback cycles. Using our proposed quantitative criteria, we identify which of the positive feedback cycles in this model may be considered to be 'vicious cycles'. Finally, key points at which to block the positive feedback cycles in MM-bone interactions are identified, suggesting potential drug targets.

Citing Articles

A review of mathematical modeling of bone remodeling from a systems biology perspective.

Cook C, Lighty A, Smith B, Ford Versypt A Front Syst Biol. 2025; 4.

PMID: 40012834 PMC: 11864782. DOI: 10.3389/fsysb.2024.1368555.


Osteoporosis induced by cellular senescence: A mathematical model.

Siewe N, Friedman A PLoS One. 2024; 19(5):e0303978.

PMID: 38805428 PMC: 11132490. DOI: 10.1371/journal.pone.0303978.


The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease.

Bishop R, Miller A, Froid M, Nerlakanti N, Li T, Frieling J Nat Commun. 2024; 15(1):2458.

PMID: 38503736 PMC: 10951361. DOI: 10.1038/s41467-024-46594-0.


Management of Myeloma Bone Lesions.

Du J, Yen C, Hsu C, Hsiao H Int J Mol Sci. 2021; 22(7).

PMID: 33806209 PMC: 8036461. DOI: 10.3390/ijms22073389.


Toward a Mathematical Modeling of Diseases' Impact on Bone Remodeling: Technical Review.

Ait Oumghar I, Barkaoui A, Chabrand P Front Bioeng Biotechnol. 2020; 8:584198.

PMID: 33224935 PMC: 7667152. DOI: 10.3389/fbioe.2020.584198.


References
1.
Harada S, Rodan G . Control of osteoblast function and regulation of bone mass. Nature. 2003; 423(6937):349-55. DOI: 10.1038/nature01660. View

2.
Klein B, Zhang X, Lu Z, Bataille R . Interleukin-6 in human multiple myeloma. Blood. 1995; 85(4):863-72. View

3.
Alexandrakis M, Passam F, Malliaraki N, Katachanakis C, Kyriakou D, Margioris A . Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients. Clin Chim Acta. 2002; 325(1-2):51-7. DOI: 10.1016/s0009-8981(02)00246-2. View

4.
Mitsiades C, Mitsiades N, Richardson P, Munshi N, Anderson K . Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment. J Cell Biochem. 2007; 101(4):950-68. DOI: 10.1002/jcb.21213. View

5.
Raitakari M, Brown R, Sze D, Yuen E, Barrow L, Nelson M . T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells. Br J Haematol. 2000; 110(1):203-9. DOI: 10.1046/j.1365-2141.2000.02131.x. View